High affinity monoclonal antibody targeting Siglec-15 for cancer immunotherapy.
Journal of clinical and translational research(2021)
Abstract
The anti-Siglec-15 mAb prepared in this study is useful as an immune checkpoint inhibitor against Siglec-15 for normalization cancer immunotherapy. This immunotherapy provides an alternative treatment for cancer patients who are refractory to the well-known PD-L1/PD-1-targeting therapies.
MoreTranslated text
Key words
Siglec-15,cancer immunotherapy,fluorescent-activated cell sorting,hybridoma cell,monoclonal antibody
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined